Latest updates for Gene Therapy

Fresh curated links around gene therapy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • ASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapy
  • rAAV8 HMR-001 Boosts Liver Gene Therapy in Hemophilia
  • Gene Therapy for Inherited Deafness Shows Lasting Hearing Restoration

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

genengnews.com /2 weeks ago

ASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapy

Beverly Davidson, PhD, chief scientific strategy officer at Children's Hospital of Philadelphia, shares her research including a novel gene therapy approach for Huntington's diseas...

Read source
bioengineer.org /2 weeks ago

rAAV8 HMR-001 Boosts Liver Gene Therapy in Hemophilia

In a groundbreaking advancement for gene therapy, researchers have unveiled two novel bioengineered AAV8 vectors—HMR-001 and its codon-optimized counterpart HMR-001z—that demonstra...

Read source
hearingreview.com /4 weeks ago

Gene Therapy for Inherited Deafness Shows Lasting Hearing Restoration

A multicenter study found a one-time treatment targeting the OTOF gene restored hearing in most participants, with effects lasting up to 2.5 years.

Read source
genengnews.com /4 weeks ago

Top 10 Best Selling Gene Therapies

As more products reach the market, therapy developers partner with researchers and regulators to deliver N-of-1 treatments to patients. The post Top 10 Best Selling Gene Therapies...

Read source
neurosciencenews.com /4 days ago

Gene Therapy Proven to Shield Brain from TDP-43 Damage

An experimental gene therapy called SynCav1 can protect the central nervous system from the cognitive decline linked to TDP-43-related proteinopathy, a primary driver of FTD, ALS,...

Read source
bioengineer.org /1 month ago

Non-Viral Large DNA Integration in Human T Cells

A groundbreaking advancement in gene editing heralds a new era for immunotherapy, addressing the longstanding challenges of integrating large DNA sequences into primary human T cel...

Read source
genengnews.com /4 weeks ago

Going Non-Viral: Gene Delivery Enters Its Translation Era

Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines. The post Going Non-Vira...

Read source
drugs.com /1 month ago

First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval

MONDAY, April 27, 2026 — In a historic leap for medical science, the U.S. Food and Drug Administration (FDA) has greenlit the first-ever gene therapy to treat a rare form of inheri...

Read source
nanowerk.com /1 month ago

Building a better delivery system for gene editing machines by re-engineering the cellular factory

A new study improves gene editing delivery by engineering the human cells that produce virus-like particles, boosting the potency of these key therapeutic vehicles.

Read source
genengnews.com /1 month ago

Genetic Medicine Delivery Enhanced by Producer Cell Modifications

A new platform based on genome-wide screening systemically identifies which genes drive or block particle assembly to engineer cells that yield more potent delivery vehicles.  The...

Read source
bioengineer.org /1 month ago

Revolutionizing Gene Editing: Enhancing Delivery Systems Through Cellular Factory Re-Engineering

Gene editing represents one of the most transformative advances in modern medicine, offering the potential to correct genetic diseases at their source. However, a major obstacle in...

Read source
fightaging.org /1 month ago

NPPA Gene Therapy to Encourage Greater Regeneration Following Heart Attack

Researchers here describe a novel approach to encourage greater regeneration in heart tissue following the injury and lost function incurred during a heart attack. Their work falls...

Read source
biopharmadive.com /3 weeks ago

With $97M, Latus pursues a different kind of Huntington’s gene therapy

The therapy is part of a plan to develop gene therapies that can be efficiently delivered at lower doses, enabling them to be used against more than just “ultra-rare” conditions.

Read source
fiercebiotech.com /1 month ago

Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval

Travis Smith was a very serious baby. Born completely unable to hear, his mother, Sierra, struggled to see his personality shine through his mute world.

Read source
genengnews.com /4 weeks ago

Gene Editing at Scale, Clinic Seeks Generalizable Therapies

What’s most exciting about CRISPR is its potential to shift medicine from managing disease to directly correcting its root cause. End-to-end pipelines and regulatory advances aim t...

Read source
futurism.com /1 week ago

Gene Therapy Causes Patient to Grow Alarming Tumor

Tinkering with the genetic code of a living human is risky. The post Gene Therapy Causes Patient to Grow Alarming Tumor appeared first on Futurism.

Read source
arstechnica.com /1 month ago

Clinical trial shows gene editing works for β-Thalassaemia, too

Improved gene editing process reactivates the fetal version of a hemoglobin gene.

Read source
labiotech.eu /1 month ago

The future of cell & gene therapy: Key trends to watch

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends. The post The future of cell & gene ther...

Read source
drugs.com /1 month ago

Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds

THURSDAY, April 23, 2026 — A new gene therapy to treat inherited deafness produces a lasting cure, a new international study has found. The treatment, which targets the OTOF gene,...

Read source
bioengineer.org /3 weeks ago

Effective AAV Gene Therapy in Late-Stage Lysosomal Disease

In a groundbreaking advancement in the field of gene therapy, researchers have demonstrated a significant clinical response following systemic administration of adeno-associated vi...

Read source
jdsupra.com /2 weeks ago

Federal Circuit Confirms Patent Eligibility of Gene Therapy Patent in Regenexbio Inc. v. Sarepta Therapeutics

Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being markedly different from anything occurring in...

Read source
genengnews.com /2 weeks ago

Acute Myeloid Leukemia Therapy Improved by CRISPR Stem Cell Transplant

A Phase I/II clinical trial shows that a stem cell transplant that removes CD33 from donor cells using CRISPR can prevent cancer recurrence. The post Acute Myeloid Leukemia Therapy...

Read source
hearingreview.com /1 month ago

FDA Grants Accelerated Approval to Otarmeni Gene Therapy for OTOF-Related Hearing Loss

The adeno-associated virus vector-based gene therapy is indicated for pediatric and adult patients with severe-to-profound hearing loss due to biallelic OTOF gene variants.

Read source
genengnews.com /3 weeks ago

G-Link CAR-T Delivery Platform Showcased at ASGCT

The modular plug-and-play protein adapter developed in collaboration with Menachem Rubenstein, PhD, of the Weizmann Institute allows drug developers to cap and retarget existing le...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Gene Therapy

feeds.arstechnica.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

futurism.com

Recent coverage from public sources
Public source

neurosciencenews.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source